secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2022-11-01T23:59:59+00:00
Accession:  0001609550-22-000047
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical Q3 revenue $109.2M (+77% YoY); raises FY2022 guidance to $384-388M
--------------------------------------------------------------------------------

- Revenue $109.2M (+77% YoY); raised FY2022 guidance to $384-388M from $354-362M.
- Gross margin 81.9% (down from 86.0%) on inventory obsolescence and inflation; FY margin guidance maintained at 83-85%.
- Net loss $16.8M ($0.60 diluted EPS) vs $10.3M ($0.38); cash $427.5M after $243.8M public offering.
- Added 59 new U.S. centers (total 844) and 18 sales territories (total 209); launched Bluetooth remote and silicone leads.
- European revenue down 14% on FX; France final pricing secured, reimbursement expected early 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955022000047/0001609550-22-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955022000047/insp-20221101.htm
  HTML page:      https://secwatch.observer/filing/0001609550-22-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer